{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:19:07Z","timestamp":1786997947459,"version":"build-2736575974"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["200\\u20132018-96321"],"award-info":[{"award-number":["200\\u20132018-96321"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["200\\u20132012-52242"],"award-info":[{"award-number":["200\\u20132012-52242"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.vaccine.2026.128289","type":"journal-article","created":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T18:59:41Z","timestamp":1769885981000},"page":"128289","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["A phase 4, open-label, single arm, multi-center study to evaluate the safety of a smallpox vaccine in previously vaccinated individuals"],"prefix":"10.1016","volume":"75","author":[{"given":"David","family":"Cassie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanja","family":"Komlenovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geraldine","family":"Parrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bojan","family":"Drobic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.128289_bb0005","author":"ACAM2000\u00ae"},{"issue":"10","key":"10.1016\/j.vaccine.2026.128289_bb0010","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/j.vaccine.2008.11.079","article-title":"Comparison of the safety and immunogenicity of ACAM1000, ACAM2000, and Dryvax in healthy vaccinia-na\u00efve adults","volume":"27","author":"Frey","year":"2009","journal-title":"Vaccine"},{"issue":"25","key":"10.1016\/j.vaccine.2026.128289_bb0015","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1016\/j.vaccine.2005.01.079","article-title":"A novel, cell culture-derived smallpox vaccine in vaccinia na\u00efve adults","volume":"23","author":"Artenstein","year":"2005","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128289_bb0020","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3121\/cmr.1.2.87","article-title":"Smallpox vaccine: the good, the bad, and the ugly","volume":"1","author":"Belongia","year":"2003","journal-title":"Clin Med Res"},{"key":"10.1016\/j.vaccine.2026.128289_bb0025","first-page":"145","article-title":"Declaration of global eradication of smallpox","volume":"55","author":"World Health Organization","year":"1980","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2026.128289_bb0030","first-page":"339","article-title":"Public health service recommendations on smallpox vaccination","volume":"20","author":"CDC","year":"1971","journal-title":"MMWR"},{"key":"10.1016\/j.vaccine.2026.128289_bb0035","first-page":"9","article-title":"Recommendation of the immunization practices advisory committee (ACIP). Smallpox vaccination of hospital and health personnel","volume":"25","author":"CDC","year":"1976","journal-title":"MMWR"},{"key":"10.1016\/j.vaccine.2026.128289_bb0040","first-page":"387","article-title":"Smallpox vaccine no longer available for civilians\u2014United States","volume":"32","author":"CDC","year":"1983","journal-title":"MMWR"},{"key":"10.1016\/j.vaccine.2026.128289_bb0045","first-page":"1","article-title":"Vaccinia (smallpox) vaccine recommendations of the immunization practices advisory committee (ACIP)","volume":"40","author":"CDC","year":"1991","journal-title":"MMWR"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128289_bb0050","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1517\/13543784.17.4.555","article-title":"ACAM2000: a newly licensed cell culture-based live vaccinia smallpox vaccine","volume":"17","author":"Greenberg","year":"2008","journal-title":"Expert Opin Investig Drugs"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128289_bb0055","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2147\/DDDT.S3687","article-title":"ACAM2000: the new smallpox vaccine for United States strategic National Stockpile","volume":"25","author":"Nalca","year":"2010","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.vaccine.2026.128289_bb0060","author":"Center for Infectious Disease Research and Policy"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128289_bb0065","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3201\/eid0504.990413","article-title":"Vaccines in civilian defense against bioterrorism","volume":"5","author":"Russell","year":"1999","journal-title":"Emerg Infect Diseases"},{"key":"10.1016\/j.vaccine.2026.128289_bb0070","author":"Vaccinia Immunoglobulin Intravenous (Human) [VIGIV]"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2026.128289_bb0075","article-title":"A case series of smallpox vaccination-associated myopericarditis: effects on safety and readiness of the active-duty soldier","volume":"184","author":"Sarkisian","year":"2018","journal-title":"Mil Med"},{"key":"10.1016\/j.vaccine.2026.128289_bb0080","first-page":"282","article-title":"Vaccinia (smallpox) vaccine recommendations of the immunization practices advisory committee (ACIP)","volume":"52","author":"CDC","year":"2003","journal-title":"MMWR"},{"key":"10.1016\/j.vaccine.2026.128289_bb0085","author":"CDC"},{"issue":"21","key":"10.1016\/j.vaccine.2026.128289_bb0090","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1001\/jama.294.21.2734","article-title":"Adverse events associated with smallpox vaccination in the United States, January-October 2003","volume":"294","author":"Casey","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2026.128289_bb0095","article-title":"Unintentional transfer of vaccinia virus associated with smallpox vaccines: ACAM2000(\u00ae) compared with Dryvax(\u00ae)","volume":"Jul;9(7):1489-96","author":"Tack","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2026.128289_bb0100","doi-asserted-by":"crossref","first-page":"7323","DOI":"10.1016\/j.vaccine.2020.09.037","article-title":"Prospective safety surveillance study of ACAM2000 smallpox vaccine in deploying military personnel","volume":"38","author":"Faix","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128289_bb0105","doi-asserted-by":"crossref","first-page":"5541","DOI":"10.1016\/j.vaccine.2021.08.041","article-title":"Enhanced safety surveillance study of ACAM2000 smallpox vaccine among US military service members","volume":"39","author":"Decker","year":"2021","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26000976?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26000976?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T15:51:03Z","timestamp":1772553063000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26000976"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":21,"alternative-id":["S0264410X26000976"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128289","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A phase 4, open-label, single arm, multi-center study to evaluate the safety of a smallpox vaccine in previously vaccinated individuals","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128289","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128289"}}